0001140361-12-017923.txt : 20120328 0001140361-12-017923.hdr.sgml : 20120328 20120328175631 ACCESSION NUMBER: 0001140361-12-017923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110927 FILED AS OF DATE: 20120328 DATE AS OF CHANGE: 20120328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgin Jonathan CENTRAL INDEX KEY: 0001519448 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53708 FILM NUMBER: 12721813 MAIL ADDRESS: STREET 1: C/O BIOCANCELL THERAPEUTICS, INC. STREET 2: 8 HARTOM ST. CITY: JERUSALEM STATE: L3 ZIP: 97775 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCANCELL THERAPEUTICS INC. CENTRAL INDEX KEY: 0001451980 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204630076 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BECK SCIENCE CENTER STREET 2: 8 HARTOM STREET, HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 97775 BUSINESS PHONE: 972-2-548-6555 MAIL ADDRESS: STREET 1: BECK SCIENCE CENTER STREET 2: 8 HARTOM STREET, HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 97775 4 1 doc1.xml FORM 4 X0305 4 2011-09-27 0 0001451980 BIOCANCELL THERAPEUTICS INC. BICL.TA 0001519448 Burgin Jonathan 8 HARTOM ST JERUSALEM L3 97775 ISRAEL 0 1 0 0 Chief Financial Officer Employee Options 2011-09-27 4 A 0 300000 0 A 2021-09-27 Common Stock 300000 300000 D The exercise price is 2.90 NIS per share. 13,750 options shall vest and be exercisable at the end of each calendar quarter, from June 30, 2011 until 220,000 options are vested or until vesting is terminated in accordance with the terms of the options. An additional 80,000 options shall vest and be exercisable upon achievement of a pre-determined milestone. Jonathan Burgin 2012-03-28